{"related:yBt9acc7bVEJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5":[{"title":"Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers","url":"https://link.springer.com/article/10.1186/1472-6963-10-153","authors":["J Adamski","J Adamski B Godman","J Adamski B Godman G Ofierska"],"year":2010,"numCitations":249,"pdf":"https://link.springer.com/article/10.1186/1472-6963-10-153","citationUrl":"http://scholar.google.com/scholar?cites=5867411617187961800&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:yBt9acc7bVEJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=5867411617187961800&hl=en&as_sdt=0,5","publication":"Springer","p":1,"exp":1596876810203},{"title":"Linking payment to health outcomes: a taxonomy and examination of performance-based reimbursement schemes between healthcare payers and manufacturers","url":"https://www.sciencedirect.com/science/article/pii/S0168851010000515","authors":["JJ Carlson","JJ Carlson SD Sullivan","JJ Carlson SD Sullivan LP Garrison","JJ Carlson SD Sullivan LP Garrison PJ Neumann…"],"year":2010,"numCitations":262,"citationUrl":"http://scholar.google.com/scholar?cites=14110010433089266986&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:KmVXGbvT0MMJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=14110010433089266986&hl=en&as_sdt=0,5","publication":"Elsevier"},{"title":"Performance-based risk-sharing arrangements—good practices for design, implementation, and evaluation: report of the ISPOR good practices for …","url":"https://www.sciencedirect.com/science/article/pii/S1098301513018111","authors":["LP Garrison Jr","LP Garrison Jr A Towse","LP Garrison Jr A Towse A Briggs","LP Garrison Jr A Towse A Briggs G de Pouvourville…"],"year":2013,"numCitations":182,"pdf":"https://www.sciencedirect.com/science/article/pii/S1098301513018111","citationUrl":"http://scholar.google.com/scholar?cites=2067565791340501145&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:mZiZ_iF4sRwJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=2067565791340501145&hl=en&as_sdt=0,5","publication":"Elsevier"},{"title":"Can't get no satisfaction? Will pay for performance help?","url":"https://link.springer.com/article/10.2165/11314080-000000000-00000","authors":["A Towse","A Towse LP Garrison"],"year":2010,"numCitations":113,"citationUrl":"http://scholar.google.com/scholar?cites=1317029104487530836&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:VIHUG_4GRxIJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=1317029104487530836&hl=en&as_sdt=0,5","publication":"Springer"},{"title":"Risk-sharing arrangements that link payment for drugs to health outcomes are proving hard to implement","url":"https://www.healthaffairs.org/doi/abs/10.1377/hlthaff.2010.1147","authors":["PJ Neumann","PJ Neumann JD Chambers","PJ Neumann JD Chambers F Simon","PJ Neumann JD Chambers F Simon LM Meckley"],"year":2011,"numCitations":89,"pdf":"https://www.healthaffairs.org/doi/full/10.1377/hlthaff.2010.1147","citationUrl":"http://scholar.google.com/scholar?cites=16277511124980405535&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:HxXtTyBW5eEJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=16277511124980405535&hl=en&as_sdt=0,5","publication":"healthaffairs.org"},{"title":"The simple economics of risk‐sharing agreements between the NHS and the pharmaceutical industry","url":"https://onlinelibrary.wiley.com/doi/abs/10.1002/hec.1603","authors":["PP Barros"],"year":2011,"numCitations":52,"pdf":"https://run.unl.pt/bitstream/10362/2551/1/barros-sharing.pdf","citationUrl":"http://scholar.google.com/scholar?cites=15146604297943751064&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:mJlX3FuMM9IJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=15146604297943751064&hl=en&as_sdt=0,5","publication":"Wiley Online Library"},{"title":"Managed entry agreements for pharmaceuticals: the European experience","url":"http://eprints.lse.ac.uk/50513/1/__Libfile_repository_Content_Ferrario,%20A_Ferrario_Managed_%20entry_%20agreements_2013_Ferrario_Managed_%20entry_%20agreements_2013.pdf","authors":["A Ferrario","A Ferrario P Kanavos"],"year":2013,"numCitations":113,"pdf":"http://eprints.lse.ac.uk/50513/1/__Libfile_repository_Content_Ferrario,%20A_Ferrario_Managed_%20entry_%20agreements_2013_Ferrario_Managed_%20entry_%20agreements_2013.pdf","citationUrl":"http://scholar.google.com/scholar?cites=3410017320196808574&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:fp9CiK_QUi8J:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=3410017320196808574&hl=en&as_sdt=0,5","publication":"eprints.lse.ac.uk"},{"title":"Access with evidence development schemes","url":"https://link.springer.com/article/10.2165/11530850-000000000-00000","authors":["CJ McCabe","CJ McCabe T Stafinski","CJ McCabe T Stafinski R Edlin","CJ McCabe T Stafinski R Edlin D Menon"],"year":2010,"numCitations":90,"citationUrl":"http://scholar.google.com/scholar?cites=5965860494715276294&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:BkwK74L-ylIJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=5965860494715276294&hl=en&as_sdt=0,5","publication":"Springer"},{"title":"Risk-sharing agreements for innovative drugs","url":"https://link.springer.com/content/pdf/10.1007/s10198-006-0386-6.pdf","authors":["G De Pouvourville"],"year":2006,"numCitations":90,"citationUrl":"http://scholar.google.com/scholar?cites=9679202809995109938&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:Mqa4TqxvU4YJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=9679202809995109938&hl=en&as_sdt=0,5","publication":"Springer"},{"title":"Should Health Authorities Offer Risk-Sharing Contracts to Pharmaceutical Firms: A Theoretical Approach","url":"https://heinonline.org/hol-cgi-bin/get_pdf.cgi?handle=hein.journals/hecpol6&section=33","authors":["F Antonanzas","F Antonanzas C Juarez"],"year":2011,"numCitations":41,"citationUrl":"http://scholar.google.com/scholar?cites=10776785353669188850&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:8pwVai7VjpUJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=10776785353669188850&hl=en&as_sdt=0,5","publication":"HeinOnline"}]}